| Year |
Citation |
Score |
| 2014 |
Galasso M, Dama P, Previati M, Sandhu S, Palatini J, Coppola V, Warner S, Sana ME, Zanella R, Abujarour R, Desponts C, Teitell MA, Garzon R, Calin G, Croce CM, et al. A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Medicine. 6: 76. PMID 25352916 DOI: 10.1186/S13073-014-0076-4 |
0.584 |
|
| 2014 |
Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, Sana ME, Garzon ME, Di Leva G, Gasparini P, Dama P, et al. Pluripotent stem cell miRNAs and metastasis in invasive breast cancer. Journal of the National Cancer Institute. 106. PMID 25306216 DOI: 10.1093/Jnci/Dju324 |
0.6 |
|
| 2011 |
Cutler C, Desponts C, Robbins D, North T, Goessling W, Kao G, Ritz J, Ballen K, Antin J, Spitzer T, SoifferChenY.-B.A. R, Ho V, Armand P, Koreth J, Alyea E, et al. Ex Vivo Treatment of Hematopoietic Stem Cells With 16,16-Dimethyl Prostaglandin E2 (FT1050) Improves Engraftment and Hematopoietic Reconstitution Biology of Blood and Marrow Transplantation. 17: S226. DOI: 10.1016/J.Bbmt.2010.12.224 |
0.392 |
|
| 2010 |
Yanes O, Clark J, Wong DM, Patti GJ, Sánchez-Ruiz A, Benton HP, Trauger SA, Desponts C, Ding S, Siuzdak G. Metabolic oxidation regulates embryonic stem cell differentiation. Nature Chemical Biology. 6: 411-7. PMID 20436487 DOI: 10.1038/Nchembio.364 |
0.603 |
|
| 2010 |
Desponts C, Ding S. Using small molecules to improve generation of induced pluripotent stem cells from somatic cells. Methods in Molecular Biology (Clifton, N.J.). 636: 207-18. PMID 20336525 DOI: 10.1007/978-1-60761-691-7_13 |
0.583 |
|
| 2009 |
Hazen AL, Smith MJ, Desponts C, Winter O, Moser K, Kerr WG. SHIP is required for a functional hematopoietic stem cell niche. Blood. 113: 2924-33. PMID 19074735 DOI: 10.1182/blood-2008-02-138008 |
0.333 |
|
| 2008 |
Shi Y, Desponts C, Do JT, Hahm HS, Schöler HR, Ding S. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell. 3: 568-74. PMID 18983970 DOI: 10.1016/J.Stem.2008.10.004 |
0.644 |
|
| 2008 |
Perez LE, Desponts C, Parquet N, Kerr WG. SH2-inositol phosphatase 1 negatively influences early megakaryocyte progenitors. Plos One. 3: e3565. PMID 18958162 DOI: 10.1371/Journal.Pone.0003565 |
0.347 |
|
| 2008 |
Shi Y, Do JT, Desponts C, Hahm HS, Schöler HR, Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell. 2: 525-8. PMID 18522845 DOI: 10.1016/J.Stem.2008.05.011 |
0.555 |
|
| 2007 |
Desponts C, Ninos JM, Kerr WG. s-SHIP associates with receptor complexes essential for pluripotent stem cell growth and survival. Stem Cells and Development. 15: 641-6. PMID 17105399 DOI: 10.1089/SCD.2006.15.641 |
0.424 |
|
| 2006 |
Desponts C, Hazen AL, Paraiso KH, Kerr WG. SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation. Blood. 107: 4338-45. PMID 16467196 DOI: 10.1182/blood-2005-12-5021 |
0.38 |
|
| 2001 |
Tu Z, Ninos JM, Ma Z, Wang JW, Lemos MP, Desponts C, Ghansah T, Howson JM, Kerr WG. Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein. Blood. 98: 2028-38. PMID 11567986 DOI: 10.1182/Blood.V98.7.2028 |
0.452 |
|
| Show low-probability matches. |